THE SIGNIFICANCE OF PULMONARY ARTERIAL HYPERTENSION PRE- AND POST-TRANSFEMORAL AORTIC VALVE IMPLANTATION FOR SEVERE AORTIC STENOSIS  by Medvedofsky, Diego et al.
Valvular Heart Disease
A2026
JACC April 1, 2014
Volume 63, Issue 12
tHe sIgnIfIcance of Pulmonary arterIal HyPertensIon Pre- and Post-transfemoral 
aortIc valve ImPlantatIon for severe aortIc stenosIs
Poster Contributions
Hall C
Monday, March 31, 2014, 9:45 a.m.-10:30 a.m.
Session Title: TAVR: Patient Selection
Abstract Category: 29. Valvular Heart Disease: Therapy
Presentation Number: 1271-352
Authors: Diego Medvedofsky, Robert Klempfner, Paul Fefer, Fernando Chernomordik, Ashraf Hamdan, Ilan Hay, Ilan Goldenberg, Ehud Raanani, 
Victor Guetta, Amit Segev, The Heart Center, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
background: Trans-catheter aortic valve implantation (TAVI) has become the treatment of choice for symptomatic patients with aortic stenosis 
(AS) and high surgical risk. Pulmonary hypertension (PH) has been shown to be associated with worse outcomes after aortic valve surgery. Data 
regarding the effect of TAVI on PH are limited.
methods: We evaluated the characteristics and outcome of patients with various degrees of systolic PH referred to TAVI. PH was defined as 
systolic pulmonary arterial pressure (SPAP) ≥50mmHg as assessed by echocardiography. After TAVI, patients with SPAP decrease to <50mmHg were 
compared to patients with persistent PH.
results: Of the 122 patients included in the present study, 49 (40%) patients had elevated SPAP prior to TAVI. This group of patients presented 
with smaller aortic valve areas, greater degrees of MR or TR, lower LVEF and more prevalent COPD (all p<0.05). Following TAVI, 57% of the patients 
with prior PH experienced a reduction in SPAP to <50 mmHg. Multivariable analysis identified COPD to be the most powerful predictor for post TAVI 
PH (OR 3.9, 95%CI 1.5-9.9, p=0.005). Post TAVI PH (SPAP≥50mmHg), was associated with a 3.4-fold, independent, 2-year mortality risk (p=0.04).
conclusions: Our data suggest that TAVI is associated with a significant reduction in SPAP in more than half of patients with pre-procedural PH. 
COPD identifies patients with persistent PH after TAVI. Post TAVI PH is associated with markedly worse outcome.
